Determination of gabapentin in plasma by high-performance liquid chromatography

被引:63
作者
Forrest, G [1 ]
Sills, GJ [1 ]
Leach, JP [1 ]
Brodie, MJ [1 ]
机构
[1] UNIV GLASGOW, WESTERN INFIRM, DEPT MED & THERAPEUT, EPILEPSY RES UNIT, GLASGOW G11 6NT, LANARK, SCOTLAND
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1996年 / 681卷 / 02期
关键词
gabapentin;
D O I
10.1016/0378-4347(96)00074-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid and simple method for determination of the novel antiepileptic compound gabapentin [1-(aminomethyl)cyclohexaneacetic acid] in plasma is described. Blank human plasma was spiked with gabapentin (1.0-10.0 mu g/ml) and internal standard [1-(aminomethyl)-cycloheptaneacetic acid; 5.0 mu g/ml]. Individual samples were treated with 2 M perchloric acid, centrifuged and then derivatised with o-phthalaldehyde-3-mercaptopropionic acid. Separation was achieved on a Beekman Ultrasphere 5 mu m reversed-phase column with mobile phase consisting of 0.33 M acetate buffer (pH 3.7; containing 100 mg/l EDTA)-methanol-acetonitrile (40:30:30, v/v). Eluents were monitored by fluorescence spectroscopy with excitation and emission wavelengths of 330 and 440 nm, respectively. The calibration curve for gabapentin in plasma was linear (r=0.9997) over the concentration range 1.0-10.0 mu g/ml. Recovery was seen to be greater than or equal to 90%. The inter- and intra-assay variations for three different gabapentin concentrations were less than or equal to 10% throughout. The lower limit of quantitation was found to be 0.5 mu g/ml. Chromatography was unaffected by a range of commonly employed antiepileptic drugs or selected amino acids.
引用
收藏
页码:421 / 425
页数:5
相关论文
共 16 条
[1]   THE GENETIC ANIMAL-MODEL OF REFLEX EPILEPSY IN THE MONGOLIAN GERBIL - DIFFERENTIAL EFFICACY OF NEW ANTICONVULSIVE DRUGS AND PROTOTYPE ANTIEPILEPTICS [J].
BARTOSZYK, GD ;
HAMER, M .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1987, 19 (06) :429-440
[2]   GABAPENTIN [J].
CHADWICK, D .
LANCET, 1994, 343 (8889) :89-91
[3]  
DICHTER MA, IN PRESS NEW ENG J M
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF NEUROTRANSMITTER AMINO-ACIDS IN BRAIN [J].
DURKIN, TA ;
ANDERSON, GM ;
COHEN, DJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 428 (01) :9-15
[5]  
FOOT M, 1991, NEW ANTIEPILEPTIC DR, P109
[6]  
GARCIA LL, 1995, J CHROMATOGR B, V669, P157
[7]   GABAPENTIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN EPILEPSY [J].
GOA, KL ;
SORKIN, EM .
DRUGS, 1993, 46 (03) :409-427
[8]   DETERMINATION OF GABAPENTIN IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND PRE-COLUMN LABELING FOR ULTRAVIOLET DETECTION [J].
HENGY, H ;
KOLLE, EU .
JOURNAL OF CHROMATOGRAPHY, 1985, 341 (02) :473-478
[9]   DETERMINATION OF GABAPENTIN IN PLASMA AND URINE BY CAPILLARY COLUMN GAS-CHROMATOGRAPHY [J].
HOOPER, WD ;
KAVANAGH, MC ;
DICKINSON, RG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (01) :167-174
[10]   DELIBERATE OVERDOSE WITH THE NOVEL ANTICONVULSANT TIAGABINE [J].
LEACH, JP ;
STOLAREK, I ;
BRODIE, MJ .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1995, 4 (02) :155-157